The scientific breakthroughs by our researchers and partners are improving and saving millions of lives every year, and we continue to research and develop essential radioisotopes used in treatments that benefit the citizens of Missouri and the nation. The FDA approved Pluvicto for treatment of metastatic prostate cancer in March 2022
The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages
0.1% RGN-259 (Thymosin 4) ophthalmic solution promotes healing and improves comfort in neurotrophic keratopathy patients in a randomized, placebo-controlled, double-masked Phase III clinical trial
Research findings: Studies on TB-500 show promising effects on skin wound healing, post-infarction cardiac repair (murine models), muscle injury recovery, and improved joint mobility
This characteristic makes KPV a uniquely accessible tool for intestinal inflammation research compared to most research peptides, which are degraded before reaching gut tissue
NAD+ Therapy FAQs NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells